Form 4: Dorman Products CFO Sells Shares

Sentiment:

Insider Transaction Report 3 November 2025 4:22 PM

Dorman Products' SVP and CFO, David Hession, sold a total of 12,493 shares of common stock across three transactions on October 31, 2025.

Worse than expectedSVP and CFO David Hession sold a significant number of shares, which can be interpreted by the market as a lack of confidence or a belief that the stock is fully valued.

Summary

David Hession, the Senior Vice President and Chief Financial Officer of Dorman Products, Inc. (DORM), reported the sale of common stock.
On October 31, 2025, Hession executed three separate transactions to dispose of shares.
The first transaction involved the sale of 3,120 shares at a weighted average price of $134.1413 per share.
The second transaction involved the sale of 6,515 shares at a weighted average price of $135.4151 per share.
The third transaction involved the sale of 2,858 shares at a weighted average price of $136.3292 per share.
Following these transactions, David Hession beneficially owns 5,638.6363 shares of Dorman Products common stock.

Sentiment

Score: 4

Explanation: The sale of a significant number of shares by a key executive can be perceived negatively by investors, potentially signaling a belief that the stock's current valuation is high or that future prospects are less robust.

Negatives

SVP and CFO David Hession disposed of 12,493 shares of Dorman Products common stock, which can be interpreted by the market as a lack of confidence or a belief that the stock is fully valued.

Stakeholder Impact

Shareholders may interpret the insider sale as a negative signal regarding the company's future stock performance or valuation.

Key Dates

Date	Description
10/31/2025	Date of earliest transaction (sale of common stock)
11/03/2025	Signature date of the reporting person

Recommendation

hold

The sale of shares by a key executive, such as the SVP and CFO, can be a concerning signal for investors, potentially indicating that the insider believes the stock is fully valued or that future growth may be limited. However, without additional context on the executive's personal financial planning or the company's broader financial performance, a 'hold' recommendation is prudent. Investors should monitor future insider activity and company announcements for further insights.

Keywords

Dorman Products, DORM, insider trading, Form 4, stock sale, David Hession, CFO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.